Baker Brothers Advisors - VAXCYTE INC ownership

VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$2,492,157
+2.1%
48,8850.0%0.01%0.0%
Q2 2023$2,441,317
+33.2%
48,8850.0%0.01%
+40.0%
Q1 2023$1,832,210
-21.8%
48,8850.0%0.01%
-28.6%
Q4 2022$2,344,03648,8850.01%
Other shareholders
VAXCYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,049,893$53,523,54517.09%
Pivotal bioVenture Partners Investment Advisor LLC 793,036$40,429,12816.12%
Kynam Capital Management, LP 1,302,407$66,396,70910.86%
RA Capital Management 7,891,254$402,296,1297.92%
COMMODORE CAPITAL LP 1,100,000$56,078,0006.56%
GREAT POINT PARTNERS LLC 531,211$27,081,1374.93%
ACUTA CAPITAL PARTNERS, LLC 121,022$6,169,7024.14%
Frazier Life Sciences Management, L.P. 1,164,405$59,361,3673.94%
Novo Holdings A/S 845,000$43,078,1003.18%
BRAIDWELL LP 1,619,553$82,564,8122.61%
View complete list of VAXCYTE INC shareholders